Article

Low Back Pain Improved With Stratified Management in Primary Care

Outcomes in patients with low back pain improve significantly with a stratified management approach in primary care that combines prognostic screening and treatment targeting.

Hill JC, Whitehurst DG, Lewis M, et al, Keele University, Stoke-on-Trent, United Kingdom, and other centers. Comparison of stratified primary care management for low back pain with current best practice (STarT Back): a randomised controlled trial. Lancet. 2011;378:1560-1571.

Outcomes in patients with low back pain (LBP) improve significantly with a stratified management approach in primary care that combines prognostic screening and treatment targeting. Such an approach is associated with substantial economic benefits compared with current best practice.

Hill and associates compared the clinical effectiveness and cost-effectiveness of stratified primary care (intervention) with nonstratified current best practice (control) in 1573 adults with LBP. The effect of treatment on the Roland Morris Disability Questionnaire (RMDQ) score at 12 months was the primary outcome. The analysis of cost-effectiveness focused on estimation of mean incremental quality-adjusted life years and LBP-related health care costs.

Overall, a larger reduction in RMDQ score was seen in the intervention group than in the control group. The between-group adjusted mean differences in change in RMDQ scores were significant at 4 months and 12 months. Significant improvements also were noted in secondary outcomes, such as catastrophizing, fear, and depression. Stratified care was associated with improved health-related quality of life, a reduction in health care use, and fewer days off work related to LBP.

The authors suggested that their findings represent an important advance in primary care management of LBP and have important implications for providers of LBP services.

 

Comments about / Problems with this article? Please send feedback.

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.